Navigation Links
Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
Date:10/29/2008

SAN DIEGO, Oct. 29 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the Oppenheimer 19th Annual Healthcare Conference on November 4, 2008 at 8:40 a.m. Eastern Time (5:40 a.m. Pacific Time) at the Waldorf=Astoria Hotel in New York City. Robert E. Hoffman, Arena's Vice President, Finance and Chief Financial Officer, is scheduled to provide an overview of the company, including its clinical development and discovery programs.

A live audio webcast of the presentation will be available under the investor relations section of Arena's website at http://www.arenapharm.com. A replay of the presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds target G protein-coupled receptors, an important class of validated drug targets, and includes compounds being evaluated independently and with partners, including Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Develop
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Arena Pharmaceuticals to Report Third Quarter 2008 Financial Results and to Host Conference Call and Webcast on Thursday, October 30, 2008
2. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
3. Arena Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
6. Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
7. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
8. ThreeWire Expands Presence in the Pharmaceutical Arena
9. Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
10. Arena Pharmaceuticals Announces First Quarter 2008 Financial Results
11. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014 New spin-out from ... Cambridge Innovation Capital and Johnson & Johnson Development ... company focused on harnessing the potential of circulating ... and treatment, today announced it has raised £4m ... and including Cambridge Innovation Capital and Johnson & ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Pearl's Premium ... breakthrough in drought tolerant grass seed this week with ... seed. The announcement coincides with the fact that it ... Spring as many believe. , As of the ... and favorable reviews by industry experts and the media ...
(Date:9/22/2014)... -- Research and Markets ( http://www.researchandmarkets.com/research/94pdq3/global ... "Global Biotechnology Reagents Market 2014-2018" report to ... Biotechnology reagents are chemical compounds or substances ... and examine another substance to provide a test ... prepare, collect, and examine specimens from the human ...
(Date:9/22/2014)... the tiny cell fragments whose job it is to ... cell nucleus. But they can "feel" the physical environment ... discovered. , Platelets respond to surfaces with greater stiffness ... "turn on" other platelets and other components of the ... than we give them credit for, in that they ...
Breaking Biology Technology:Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 3Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 4Pearl's Premium Ultra Low Maintenance Lawn Seed Announces A Major Breakthrough In Drought Tolerant Grass Seed 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 3Platelets modulate clotting behavior by 'feeling' their surroundings 2
... , the rock concert designed to shed light (and some money) ... in Chicago. , ,As indicated by the Chicago Tribune ... farm is not only a center of production. Its also a ... Tribune noted that we all lose something each time a ...
... Wis . - GenTel BioSurfaces, Inc. has launched PATHT ... HTS was introduced last week at the microarray industry's ... customers have been very pleased with the performance of ... of business development for GenTel BioSurfaces. "PATH ...
... The NeuronFarm, a developer of Web-based applications intended ... immediate availability of its flagship product, 3D-Readers. , ... third through eighth graders in several school studies, ... automated text scoring, engaging simulations and immediate feedback ...
Cached Biology Technology:Farm Aid celebrates 20-year journey, heads back to Illinois roots 2Farm Aid celebrates 20-year journey, heads back to Illinois roots 3NeuronFarm's 3D-Reader ready to ship 2
(Date:9/22/2014)... American Cancer Society study suggests that participants in ... as the food stamp program, had lower dietary ... authors say the findings emphasize the need to ... of SNAP participants. , The SNAP program aims ... resources to obtain a nutritionally adequate diet. In ...
(Date:9/22/2014)... researchers are studying a potential new treatment that reverses ... which scars develop in the lungs and severely hamper ... which is delivered to lung tissue intravenously. In mouse ... fibrosis after several days. , The findings were ... Medicine . , "The mimic, when injected into the ...
(Date:9/22/2014)... (Sept. 22, 2014) As genetic sequencing technologies ... there is a critical need to establish appropriate policies ... ethical experts have said. A special policy issue of ... published online today and edited by experts with the ... College of Medicine gives policy makers the tools to ...
Breaking Biology News(10 mins):Federal food program puts food on the table, but dietary quality could be improved 2Reversing the effects of pulmonary fibrosis 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 3
... apnea (OSA) is a disorder in which there are recurring episodes ... OSA is estimated to affect 1 in 5 adults in America. ... study which found that middle-age and older men with even mild ... and death. While a link between OSA and stroke is clear, ...
... stage may offer the best chance for establishing proper ... as immunosignaturing harnesses the human immune system as an ... body that may be harbingers of illness. ... guidance of Stephen Albert Johnston, director of the Center ...
... historically associated with cat scratch fever and transmitted predominately by ... such as arthritis, according to new research from North Carolina ... is maintained in nature by fleas, ticks and other biting ... parasites as well as by bites or scratches from infected ...
Cached Biology News:Obstructive sleep apnea's damage evident after 1 month 2Immunosignaturing: An accurate, affordable and stable diagnostic 2Immunosignaturing: An accurate, affordable and stable diagnostic 3Immunosignaturing: An accurate, affordable and stable diagnostic 4Bartonella infection associated with rheumatoid illnesses in humans 2
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Mus musculus MARCKS-like protein, mRNA...
Tris-Hepes kit of BG-163 & BG-165 (order number BG-166)...
... HandyStep electronic from BRAND adds ergonomics ... is the only electronic, motor-driven repeating ... tips, including BRAND PD-Tip syringe tips, ... Dispenser Tips,and VWRbrand Combi-Syringes. Select virtually ...
Biology Products: